QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
30 janv. 2023 08h30 HE
|
QHSLab, Inc.
QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors focused on the digital health community, many of which are...
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
14 nov. 2022 08h30 HE
|
QHSLab, Inc.
This forecast is based on estimates generated through a recent pilot program and scaled through approximately 250,000 independent primary care practitioners in the United States. ●National reports...
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force
01 nov. 2022 08h30 HE
|
QHSLab, Inc.
The latest recommendations from the U.S. Preventive Services Task Force (USPSTF) indicate that all adults under the age of 65 be screened for anxiety and depression in primary care including children...
QHSLab, Inc. Launches a “Long COVID” Digital Health Tool for Primary Care Physicians
20 sept. 2022 08h30 HE
|
QHSLab, Inc.
Primary care physicians now have access to reimbursable digital tools for the routine assessment of post-COVID conditions Strengthening QHSLab’s Business Model and Expanding Digital Health Product...
QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services
24 juin 2022 08h30 HE
|
QHSLab, Inc.
This Partnership Expands QHSLab’s Independent Practitioner Network, While Addressing Current Industry Pain Points. WEST PALM BEACH, FL, June 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB:...
QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
24 mai 2022 08h00 HE
|
QHSLab, Inc.
WEST PALM BEACH, FL, May 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through...
New $90 million annual addressable market for QHSLab’s latest product, the Allergy Quick Test, branded AllergiQT™.
10 mai 2022 08h30 HE
|
QHSLab, Inc.
WEST PALM BEACH, FL, May 10, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through...
QHSLab. Issues Update and Investor Presentation May 2022
09 mai 2022 08h30 HE
|
QHSLab, Inc.
Superior Business Model and Strategic Position Validated By Repeat Ordering Client Base and New Developments to Product Portfolio Addressable Market Opportunity Includes Over 250,000...
USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.
19 avr. 2022 08h30 HE
|
QHSLab, Inc.
The name change comes from the strong brand recognition garnered by the company’s flagship product, QHSLab WEST PALM BEACH, FL, April 19, 2022 (GLOBE NEWSWIRE) -- USA Equities Corp (USAQ: OTCQB)...
USA Equities Corp. Reports Fourth Quarter and Full Year 2021 Financial Results
05 avr. 2022 08h00 HE
|
USA Equities Corp
Fourth Quarter 2021 Revenue Up 265% ●Revenue Surpassed $1.4 million for the year ended 2021 Compared to $124,000 for 2020●Gross Margin of 52% in Q4 Increased 1,200 Basis Points Versus Q4 2020●Strong...